Skip to main content

Acute Coronary Syndrome - Prophylaxis News

ACC: Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome

MONDAY, April 8, 2024 – Treatment with ticagrelor alone results in a lower rate of clinically relevant bleeding compared with ticagrelor and aspirin among patients with an acute coronary syndrome...

ACC: Coronary Artery Calcium Progression May Accelerate After Menopause

TUESDAY, April 2 – Postmenopausal changes may accelerate coronary artery calcium (CAC) progression in women, according to a study presented at the annual meeting of the American College of...

Inorganic Nitrate Treatment Cuts Rate of Contrast-Induced Nephropathy

THURSDAY, March 28, 2024 – For patients presenting with acute coronary syndromes (ACS) undergoing coronary angiography, inorganic nitrate treatment reduces the rate of contrast-induced nephropathy...

No Racial Disparities Seen in Long-Term MACE for Women With CAD

MONDAY, Oct. 30, 2023 – For women with obstructive coronary artery disease (CAD), there are no racial and ethnic disparities in long-term major adverse cardiovascular events (MACE) or cardiovascular...

TCT: Ticagrelor Monotherapy Within One Month of DAPT Noninferior to Continued DAPT

FRIDAY, Oct. 27, 2023 – For patients with acute coronary syndrome (ACS), stopping dual antiplatelet therapy (DAPT) within one month for ticagrelor monotherapy is noninferior and superior to 12...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related drug support groups

Plavix, clopidogrel